logo

For the Inventor, By the Inventor

Berlin, Germany

Bernd Radüchel

This inventor holds 5 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Other. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Radüchel. Retrieved from https://idiyas.com/inventor/bernd-radanduumlchel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal4 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 834,453 
Other
 patents

Years Active: 2001-2003

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6565830 - DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production (2003-05-20),
2. 6495118 - Lipophilic metal complexes for necrosis and infarction imaging (2002-12-17),
3. 6468502 - Metal complexes that contain perfluoroalkly, process for their production and their use in NMR diagnosis (2002-10-22),
4. 6426059 - Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes (2002-07-30),
5. 6287538 - DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production (2001-09-11),

Title: **Bernd Radüchel: Innovator in Pharmaceutical Imaging**

Introduction

Bernd Radüchel, an inventive mind based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals and medical imaging. With a total of 5 patents to his name, Radüchel's work focuses on advancing diagnostic techniques and enhancing the efficacy of pharmaceutical agents.

Latest Patents

Among his most recent innovations are the patents for DTPA monoamides and pharmaceutical agents containing these compounds, alongside their processes for production. Additionally, he has developed lipophilic metal complexes for necrosis and infarction imaging. This particular invention describes a novel use of metal complexes that bond with plasma proteins at a level of at least 10%, serving as effective diagnostic agents for identifying infarctions or necrosis through enduring positive visualization.

Career Highlights

Radüchel's career has involved key roles in several prominent organizations, notably Schering Aktiengesellschaft. His scientific contributions have significantly shaped the landscape of pharmaceutical research and development.

Collaborations

Throughout his career, Bernd Radüchel has collaborated with distinguished professionals in the field, including Johannes Platzek and Hanns-Joachim Weinmann. These partnerships have fostered innovation and propelled advancements in medical imaging technologies.

Conclusion

In conclusion, Bernd Radüchel exemplifies the spirit of innovation within the realm of pharmaceuticals, especially in Diagnostic imaging. His contributions through patents reflecting significant research will undoubtedly continue to inspire future developments in medical diagnostics and treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…